Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA clears new left-heart access system from Atraverse Medical
The Hotwire Transseptal Access System includes the Hotwire RF Generator and Hotwire RF Guidewire, giving electrophysiologists the tools they need for left-heart access.
Medtronic launches new diabetes tech integrated with Abbott sensor
Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.
$V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.$
FDA panel votes against approving first-of-its-kind heart failure device
All 15 members of the FDA's Circulatory System Devices Panel agreed that more data is required to confirm the new device from Johnson & Johnson MedTech is effective. Will the agency agree with these recommendations? Only time will tell.
FDA issues warning about Olympus ligating devices after 113 injuries
The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.
Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.

heart data research doctor cardiologist AI

Mitral annular calcification linked to higher heart failure risks

In fact, researchers wrote, MAC appears to influence a patient's odds of developing HFpEF even more than their BMI.

FDA panel to review first heart failure device of its kind

The shunt device being reviewed showed a 52% reduction in hospitalizations and favorable trends in mortality in patients with heart failure with reduced ejection fraction.

Shockwave Medical Javelin Peripheral IVL Catheter

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data

The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.

startup business healthcare medtech heart

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device

Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.

Dexcom is recalling a specific version of the Android smartphone app associated with its G6 Continuous Glucose Monitoring (CGM) System.

FDA highlights new Class I recall for Dexcom CGM app

Dexcom recalled its G6 smartphone app after a software error was causing it to stop working with no warning. This is a Class I recall, which means failing to follow the company's instructions could result in a serious adverse event.

Telehealth ketamine service sued after patient dies of overdose

Mindbloom, a telemedicine company that provides ketamine for depression and anxiety as part of a treatment program, is accused of negligence in the death of Philip Ward. But the facts leading up to his overdose are in dispute.

The Penumbra thrombectomy pulmonary embolism clots extraction catheter displayed at TCT 2025. Photo by Dave Fornell

Pulmonary embolism thrombectomy use increases by more than 700%

Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).

Well-known cardiologist Peter A. Soukas, MD, FACC, FSCAI, FSVM, FACP, has become chief medical officer of carotid stent maker InspireMD Inc.

Cardiologist Peter Soukas becomes chief medical officer of carotid stent company

The company said the move will help it prepare for what is expected to be a rapid expansion of carotid stenting.

Clinical

FDA clears new left-heart access system from Atraverse Medical

Medtronic launches new diabetes tech integrated with Abbott sensor

FDA panel votes against approving first-of-its-kind heart failure device

FDA issues warning about Olympus ligating devices after 113 injuries

Patient communication AI company receives $65M in funding from private equity